trial

ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in Schizophrenia

NCTId NCT06993831
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 30 (actual)
Sponsored by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Primary completion 2026-01-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
30 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2024-12-09
Primary completion
2026-01-07
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
Virtual Reality-based psychotherapy

Sponsors

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalLead Sponsor
Glostrup University Hospital, CopenhagenCollaborator

Investigators

1
Louise B Glenthøj, PhD, dr.med.Principal Investigator

Sites

1 total
Hellerup, Denmark

Facts & assertions

4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2026-01-07
Status
COMPLETED
relationships
The graph out of here
drug
Virtual Reality-based psychotherapy
drug
lead_sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
company
collaborator
Glostrup University Hospital, Copenhagen
company
indication
Negative Symptoms in Schizophrenia
indication
Schizophrenia
indication
Schizophrenia Spectrum Disorders
indication
investigator
Louise B Glenthøj, PhD, dr.med.
person